The conundrum of clinical trials in adult germ-cell tumours

被引：2
|
作者：
Powles, Thomas [1 ]
Kollmannsberger, Christian [2 ]
Feldman, Darren R. [3 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, London EC1A 7BE, England
[2] British Columbia Canc Agcy, Christian Kurt Div Med Oncol, Vancouver, BC V5Z 4E6, Canada
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 01期
关键词：
MEDICAL-RESEARCH-COUNCIL; RANDOMIZED PHASE-III; EUROPEAN ORGANIZATION; CISPLATIN; ETOPOSIDE; CANCER; BLEOMYCIN; CHEMOTHERAPY; IFOSFAMIDE; INTERGROUP;
D O I：
10.1016/S1470-2045(12)70561-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 15
页数：3
相关论文
共 50 条
  • [41] SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023)
    Arija, Jose Angel Arranz
    del Muro, Xavier Garcia
    Caro, Raquel Luque
    Mendez-Vidal, Maria Jose
    Perez-Valderrama, Begona
    Aparicio, Jorge
    Duran, Miguel Angel Climent
    Diaz, Cristina Caballero
    Duran, Ignacio
    Gonzalez-Billalabeitia, Enrique
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2783 - 2799
  • [42] Long-term sexual functioning in germ-cell tumor survivors
    Chovanec, M.
    Vasilkova, L.
    Petrikova, L.
    Obertova, J.
    Palacka, P.
    Rejlekova, K.
    Sycova-Mila, Z.
    Kalavska, K.
    Svetlovska, D.
    Mladosievicova, B.
    Mardiak, J.
    Mego, M.
    BMC CANCER, 2020, 20 (01)
  • [43] ADULT TERATOMA AS LATE RECURRENCE OF METASTASIZED NONSEMINOMATOUS GERM-CELL TUMOR - CASE-REPORT AND CLINICAL IMPLICATIONS
    KUCZYK, MA
    BOKEMEYER, C
    FICHNA, B
    TRUSS, M
    SCHMOLL, HJ
    JONAS, U
    UROLOGE-AUSGABE A, 1995, 34 (06): : 480 - 484
  • [44] SEQUENTIAL TRIALS OF CISPLATIN, VINBLASTINE, AND BLEOMYCIN AND ETOPOSIDE AND CISPLATIN IN DISSEMINATED NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS WITH A GOOD PROGNOSIS AT A SINGLE INSTITUTION
    GERMA, JR
    SAGARRA, AF
    IZQUIERDO, MA
    SEGUI, MA
    CANCER, 1993, 71 (03) : 796 - 803
  • [45] Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
    Loriot, Y.
    Pagliaro, L.
    Flechon, A.
    Mardiak, J.
    Geoffrois, L.
    Kerbrat, P.
    Chevreau, C.
    Delva, R.
    Rolland, F.
    Theodore, C.
    Roubaud, G.
    Gravis, G.
    Eymard, J. C.
    Malhaire, J. P.
    Linassier, C.
    Habibian, M.
    Martin, A. L.
    Journeau, F.
    Reckova, M.
    Logothetis, C.
    Laplanche, A.
    Le Teuff, G.
    Culine, S.
    Fizazi, K.
    EUROPEAN JOURNAL OF CANCER, 2017, 87 : 140 - 146
  • [46] Serum tumor markers and their utilization in the management of germ-cell tumors in adult males
    Salem, Mohamed
    Gilligan, Timothy
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (01) : 1 - 4
  • [47] Systemic immune-inflammation index in germ-cell tumours: search for a biological prognostic biomarker
    Albany, Costantine
    BRITISH JOURNAL OF CANCER, 2018, 118 (06) : 761 - 762
  • [48] GERM-CELL TUMOR IN THE HYPOTHALAMONEUROHYPOPHYSEAL REGION - CLINICAL-FEATURES AND TREATMENT
    NISHIO, S
    INAMURA, T
    TAKESHITA, I
    FUKUI, M
    KAMIKASEDA, K
    NEUROSURGICAL REVIEW, 1993, 16 (03) : 221 - 227
  • [49] Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors
    Chovanec, Michal
    Vasilkova, Lucia
    Setteyova, Lucia
    Obertova, Jana
    Palacka, Patrik
    Rejlekova, Katarina
    Sycova-Mila, Zuzana
    Kalavska, Katarina
    Svetlovska, Daniela
    Cingelova, Silvia
    Mladosievicova, Beata
    Mardiak, Jozef
    Mego, Michal
    ONCOLOGIST, 2018, 23 (05) : 617 - 623
  • [50] Incidence and Clinical Features of Inguinal Metastases of Testicular Germ-Cell Tumors
    Angerer, Markus
    Zecha, Henrik
    Wuelfing, Christian
    Dieckmann, Klaus Peter
    UROLOGIA INTERNATIONALIS, 2025,
12345